Atlas Trials

Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome

Clinical trial NCT06465823 · RECRUITING

Trial details

NCT number
NCT06465823
Sponsor
Stefano Vicari
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Down Syndrome
Start date
2023-01-11
Primary completion
2025-12-30
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.